Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 17 | Valentine CurtisChief Financial Officer | Grant or award | A | — 3,786 sh | Mar 16, 2026 |
| 17 | Uczekaj JohnDirector, President and COO | Open-market sale | SELL | $4,129 396 sh | Mar 16, 2026 traded Mar 12, 2026 |
| 17 | Raiford BrittanyVP, Interim CFO & Treasurer | Grant or award | A | — 3,558 sh | Mar 16, 2026 traded Mar 15, 2026 |
| 16 | Wu LeiDirector, Chief Executive Officer, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $1.15M 26.9K sh | Mar 16, 2026 traded Mar 12, 2026 |
| 16 | Gill AnnSVP, Chief Accounting Officer | Option exercise | M | $65K 773 sh | Mar 16, 2026 traded Mar 15, 2026 |
| 16 | Kidwell CaseyChief Administration Officer | Option exercise | M | $56K 1,554 sh | Mar 16, 2026 traded Mar 12, 2026 |
| 16 | Stress Jill S.Chief Human Resources Officer | Tax withholding | F | $70K 1,999 sh | Mar 16, 2026 traded Mar 14, 2026 |
| 16 | Sousa BenChief Information Officer | Tax withholding | F | $90K 718 sh | Mar 16, 2026 traded Mar 15, 2026 |
| 16 | Hernandez Steven DennisChief Human Resources Officer | Tax withholding | F | $105K 2,858 sh | Mar 16, 2026 traded Mar 15, 2026 |
| 16 | Watson Michael JamesEVP, Head of Axos Securities | Disposition to issuer | D | $58K 685 sh | Mar 16, 2026 traded Mar 15, 2026 |
| 16 | Nichols Brian WGroup VP & Controller | Tax withholding | F | $57K 755 sh | Mar 16, 2026 traded Mar 13, 2026 |
| 16 | Moore Kathryn ASVP, HUMAN RESOURCES | Tax withholding | F | $67K 142 sh | Mar 16, 2026 traded Mar 13, 2026 |
| 16 | Robin Jodi F.General Counsel and Secretary | Tax withholding | F | $84K 2,388 sh | Mar 16, 2026 traded Mar 14, 2026 |
| 16 | Watson Michael JamesEVP, Head of Axos Securities | Disposition to issuer | D | $52K 610 sh | Mar 16, 2026 traded Mar 15, 2026 |
| 16 | Gill AnnSVP, Chief Accounting Officer | Option exercise | M | $57K 675 sh | Mar 16, 2026 traded Mar 15, 2026 |
| 15 | Wu LeiDirector, Chief Executive Officer, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $363K 8,303 sh | Mar 16, 2026 traded Mar 11, 2026 |
| 15 | Walsh Mark T.Director, CEO & Director | Option exercise | M | $269K 33.5K sh | Mar 16, 2026 traded Mar 12, 2026 |
| 15 | DeWitte JacobDirector, Co-Founder, CEO, 10% Owner | Option exercise | M | $6.70M 112.4K sh | Mar 16, 2026 traded Mar 12, 2026 |
| 15 | Cochran CarolineDirector, Co-Founder, COO, 10% Owner | Option exercise | M | $6.70M 112.4K sh | Mar 16, 2026 traded Mar 12, 2026 |
| 15 | Cochran CarolineDirector, Co-Founder, COO, 10% Owner | Option exercise | M | $4.69M 78.7K sh | Mar 16, 2026 traded Mar 12, 2026 |
| 15 | Pelish Henry E.Chief Scientific Officer | Open-market sale · 10b5-1 plan | SELL | $30K 306 sh | Mar 16, 2026 traded Mar 12, 2026 |
| 15 | Adamson Philip B.Chief Medical Officer | Open-market sale · 10b5-1 plan | SELL | $9,973 1,262 sh | Mar 16, 2026 traded Mar 2, 2026 |
| 15 | DeWitte JacobDirector, Co-Founder, CEO, 10% Owner | Option exercise | M | $4.69M 78.7K sh | Mar 16, 2026 traded Mar 12, 2026 |
| 14 | Pelish Henry E.Chief Scientific Officer | Open-market sale · 10b5-1 plan | SELL | $170K 1,703 sh | Mar 16, 2026 traded Mar 13, 2026 |
| 14 | DeWitte JacobDirector, Co-Founder, CEO, 10% Owner | Option exercise | M | — 112.4K sh | Mar 16, 2026 traded Mar 12, 2026 |
| 14 | Pelish Henry E.Chief Scientific Officer | Open-market sale · 10b5-1 plan | SELL | $79K 804 sh | Mar 16, 2026 traded Mar 13, 2026 |
| 14 | DeWitte JacobDirector, Co-Founder, CEO, 10% Owner | Option exercise | M | — 23.9K sh | Mar 16, 2026 traded Mar 12, 2026 |
| 14 | Cochran CarolineDirector, Co-Founder, COO, 10% Owner | Option exercise | M | — 5,191 sh | Mar 16, 2026 traded Mar 12, 2026 |
| 14 | Tanious Jubran N.President & COO | Grant or award | A | $1.20M 153.5K sh | Mar 16, 2026 traded Mar 12, 2026 |
| 14 | Cochran CarolineDirector, Co-Founder, COO, 10% Owner | Option exercise | M | — 78.7K sh | Mar 16, 2026 traded Mar 12, 2026 |
| 13 | Cerwin Brittany CChief Accounting Officer | Grant or award | A | — 1,807 sh | Mar 16, 2026 traded Mar 13, 2026 |
| 13 | Kidwell CaseyChief Administration Officer | Option exercise | M | $29K 831 sh | Mar 16, 2026 traded Mar 12, 2026 |
| 13 | Crow David MEVP, Head of Axos Clearing | Option exercise | M | — 738 sh | Mar 16, 2026 traded Mar 15, 2026 |
| 13 | Reed Timothy R.EVP, R&D and Tour | Option exercise | M | — 11.4K sh | Mar 16, 2026 traded Mar 14, 2026 |
| 13 | Gilligan SarahChief Sup Chn & Transform Ofcr | Tax withholding | F | $29K 1,233 sh | Mar 16, 2026 traded Mar 14, 2026 |
| 13 | Nichols Brian WGroup VP & Controller | Grant or award | A | — 921 sh | Mar 16, 2026 traded Mar 12, 2026 |
| 13 | Weigensberg AryeSee Remarks | Option exercise | M | — 26.8K sh | Mar 16, 2026 traded Mar 12, 2026 |
| 13 | Parrish DeanEVP & Chief Operating Officer | Grant or award | A | — 4,795 sh | Mar 16, 2026 traded Mar 12, 2026 |
| 13 | Fuchsen Matthew RChief Development Officer | Grant or award | A | — 2,345 sh | Mar 16, 2026 traded Mar 13, 2026 |
| 13 | Rosen TamiDirector, Chief Development Officer | Option exercise | M | — 15.6K sh | Mar 16, 2026 traded Mar 12, 2026 |